Clinical Study
A First Report on [18F]FPRGD2 PET/CT Imaging in Multiple Myeloma
Table 3
Focal lesions detected per patient.
| | Patient | Newly diagnosed MM | Relapsed-MM | Total | | # 1 | # 2 | # 3 | # 4 |
| | Concordant | 2 | 1 | 28 | 0 | 31 | | FPRG+ and NaF/FDG− | 5 | 0 | 0 | 0 | 5 | | FPRG− and NaF/FDG+ | 3 | 0 | 12 | 1 | 16 | | FPRGD2 & CT− and NaF/FDG+ | 0 | 0 | 1 | 0 | 1 | | CT− and FPRG+ | 0 | 0 | 0 | 0 | 0 | | CT+ and both PET− | 8 | 2 | 10 | 0 | 20 | | Total malignant lesions | 18 | 3 | 51 | 1 | 73 | | Fractures | 3 | 3 | 1 | 1 | 8 |
|
|
FLs showing both FPRG and NaF/FDG uptake.
|
